Real-World Evaluation of “Microhematuria” in Postmenopausal Women
•In 2012, the American Urological Association (AUA) revised the asymptomatic microscopic hematuria (AMH) guidelines to maximize detection rates of urinary tract malignancies, but unfortunately the guidelines do not explicitly address gender-specific recommendations.1
•The guidelines recommend:
1.A thorough evaluation of any patient with three or greater red blood cells per high powered field (≥3RBC/HPF) on one properly collected urinary specimen in the absence of an obvious benign cause.1
2.Cystoscopy for all patients over 35 years old
3.Upper tract imaging using multi-phasic computed tomography (CT) urography.
•Bladder cancer is 3-4 times less common in females as compared to the equivalent male population
•Prevalence of microhematuria is as high as 20.1% in postmenopausal women2
•The objective of this study was to describe adherence to AUA AMH guidelines by urology and urogynecology providers in a population of postmenopausal women at a tertiary care center.
•Additionally, we sought to assess the prevalence of urinary tract malignancy in our population of postmenopausal women.